DispatchHealth, a provider of mobile and house-call health care services, has secured a USD33 million in Series B funding round to extend its mobile app services. The funding round was led by Echo Health with further participation from Alta Partners, Questa Capital, and others. According to the announcement, the company plans to utilize this fresh capital towards opening up new locations across the U.S., as well as some of the money will also be put towards further development of the mobile app and logistics platform. Based in Denver, Colorado, DispatchHealth’s platform currently available in select parts of 8 different states enables patients to request on-demand care to their home.
After tapping DispatchHealth’s in-house health services, patients can get multiple tests from blood tests to strep and urinary tests in their home. Additionally, clinicians provide the patient with medications and certain procedures, like IV fluids. In a statement, DispatchHealth CEO and Co-founder Dr. Mark Prather stated that “All Americans deserve access to lower cost health care. Our growing senior population is a group that often faces mobility limitations and can benefit from the safe, effective and convenient care that in-home treatment provides.” He further noted that “We’re committed to helping all individuals receive the right care, at the right time, in the comfort of their own home or place of need.”
According to Parther, “The financial support and strategic expertise of Echo Health Ventures will allow us to extend our current care model into longer-term, episodic interventions for individuals requiring more advanced treatment.” The DispatchHealth’s Clinician house-call platform, at present, works with both large health systems and insurers to incorporate the patient’s care.